Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors. Learn more here: https://lnkd.in/gFavsWPF
Sagimet Biosciences’ Post
More Relevant Posts
-
#SwissBiotechDay #AkcesoAdvisors #AndrásIncze Join us at the Swiss Biotech Day next Monday and Tuesday, where our Founder & CEO, Andras Incze, will be serving as a jury member on two pitching sessions! 🎉 The Swiss Biotech Day, hosted by the Swiss Biotech Association, is one of Europe's premier biotechnology conferences, bringing together 2,000 professionals from the global life sciences community. We are very much looking forward to explore how we at Akceso Advisors could help participating biotechs make sure they maximize the value of their asset. This, by helping them reaching target price for the target patient population, thus maximizing net revenue in an ever-more-challenging pharma landscape. See you there! ✍ Find the registration link in the first comment.
To view or add a comment, sign in
-
Click the link below to find out the details about our upcoming Year-End earnings results and associated conference call!
Cellectar Biosciences to Announce 2023 Year-End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024: https://bit.ly/4czyjrs #YearEnd #ConferenceCall #Earnings
To view or add a comment, sign in
-
Discover how leading life science companies are overcoming challenges and raising significant funds to drive innovation! This panel will feature industry leaders discussing their unique scientific pursuits, products, and the financial and regulatory hurdles in today’s competitive life sciences market. 🎤 Speakers include: Jang-Ho Cha, Latus Therapeutics Josh Muntner, CFO, Imvax, Inc. Moderated by John Pennett, EisnerAmper Advisory Services. Join us for this insightful session at the Philly Builds Bio+ Third Annual Symposium! 🔗 Register today: phillybuildsbio.org #PhillyBuildsBio #LifeSciences #InvestmentOpportunities #FinancingSuccess #BiotechInnovation
To view or add a comment, sign in
-
Join Blake Mandell from Transcend Therapeutics at the upcoming Fierce Biotech Summit on Sept 30 - Oct 1 in Boston as he shares his expertise in groundbreaking biotech innovations and advancements. Register now and save up to $500 with the Early Bird Rate: https://ow.ly/uTAE50SyYgy Learn, Network and Connect over two jam-packed days with 500+ industry leaders and gain valuable insights into the future landscape of biotech. Stay Updated on all our events by following Fierce Life Sciences Events #FierceBiotechSummit #WeAreFierce #FierceBiotech #FierceBiotechSummit #BiotechInnovation #LifeSciences #PharmaIndustry #BiotechLeaders #Biotech2024 #BiotechTrends
To view or add a comment, sign in
-
I am participating LSN Webinar to share my two cents on growing interest of JP startups/biotechs on Go-to-market strategy abroad and what improvement is needed to achieve it.
On Wednesday, March 27, 7:00 – 8:30 pm EST / Thursday, March 28, 8:00 – 9:30 am JST, Life Science Nation (LSN) and Life Science Incubation Council will be organizing a 90-minute webinar including an introduction of LSN’s platform and our value-add for the global life science ecosystem, remarks from panelists who are familiar with LSN and have leveraged our platform, and pitches from companies developing innovative therapeutics. Some of the topics include Success Stories and Experiences from LSN Network featuring Toru Jay Seo, Ph.D., MBA. (Newsight Tech Angels), Yao Ho (LYFE Capital), & Thomas Forest Farb-Horch ( Thrive Bioscience, Inc.)! In addition: Innovative Drug Pipelines of LSN Clients featuring Upendra Marathi (7 Hills Pharma), Brenton Hamdorf (Celosia Therapeutics), Kay Olmstead ( (Nano Pharma Solutions), Richard Austin (Reglagene) and Luppino, Frank (Remedium Bio). Register Today: https://lnkd.in/ecccHGCE
To view or add a comment, sign in
-
Six years and more than 20 projects. Some are science fiction and some are "just" solid science. It is always great to meet a new client and learn about their ideas and dreams. It is even better to be able to transform the ideas into a workplan and a set of experiments that can make the dream a little bit more approachable. Looking forward to learning more about your new ideas; whether it is #genetherapy, #celltherapy, #ADA-assays, #bindingassay, #activityassay, #MOA, #releasetest, #diagnostics, #foodtech, or any other exciting #biochemistry.
The people building our business are more than just names on a list of profiles. They are the heart and soul of the company! ❤️ We'd like to introduce you today to Gladnikoff Micha, project manager at Smart Assays Biotechnologies Ltd.
To view or add a comment, sign in
-
⏳ Only a few days left until #SwissBiotechDay2024! Join our team, Emmanuel Chereul and Natalia NIEMIR-DEVEAU, PhD, at the Swiss Biotech Association Day to learn more about Voxcan, your CRO specialized in non-invasive high-resolution imaging for non-clinical drug development. Don’t hesitate to contact them to arrange a meeting. We look forward to meeting you and exploring how Voxcan can support your projects! See you there! #SwissBiotechDay2024 #lifescience #nonclinical #CRO #partnering #drugdevelopment #infectiousdiseases #oncology #osteoarticulardiseases #drugdiscovery
⏳ Only a few days left until #SwissBiotechDay2024! Swiss Biotech Association The ERBC Group, with Emmanuel Chereul and Natalia NIEMIR-DEVEAU, PhD, is getting ready to meet you there. Don’t hesitate to contact them to arrange a meeting. Our mission? More than a leading independent non-clinical CRO (Contract Research Organization), ERBC Group enables the evaluation of drug candidates on behalf of the pharmaceutical industry and biotechnology companies, providing all services from preclinical proof-of-concept to market. We look forward to forging new partnerships and discussing how we can advance your drug development programs. See you there! #swissbiotechday #biotechevent #lifescience #nonclinical #CRO #partnering #drugdevelopment #3Rs
To view or add a comment, sign in
-
It's clear that the Annual Meeting is more than just a conference; it's a catalyst for sparking ideas, forming relationships, and advancing progress. As Joe Lewcock, Ph.D., Chief Scientific Officer of Denali Therapeutics, eloquently expressed, "I can see it's been incredibly impactful to be involved, not just through the consortia... but through the relationships we've built at this meeting." Together, we're driving groundbreaking advancements in ALS research. #ALSResearch #EveryoneLives #ALS #EndALS #ALSAwarenessMonth
To view or add a comment, sign in
-
Women's Health Forecaster | Speaker | Trend Expert | "Trailblazing Leader in FemTech" - Women of Wearables
Well deserved! Very proud to have spotted this trend early on and featured BoobyBiome in our report last year: FemTech Futures 30: The 30 most influential trends shaping the market in 2024. In it we said: "BoobyBiome uses bacteria sourced from breast milk donated by healthy mothers. While the gut microbiome has been gaining attention in recent years, research around baby microbiomes is only just reaching public consciousness. As awareness spreads, we expect to see new regulations around microbiome-based products and therapeutics, which will give parents the peace of mind required to feed their babies probiotics and explore additional solutions for securing their healthy futures." Read the full report here: https://lnkd.in/ebCEdPg6 #trendforecasting #womenshealthtrends #trends2024 #womenshealth #femtech
I’m incredibly proud to announce that we’ve secured a £1.6M Biomedical Catalyst grant to test and scale up our BoobyBiome Synbiotic. A huge thank you to Innovate UK for their continued support. We’re also thrilled to welcome our new investors, Evenlode Investment, Kayan Ventures, and a group of angel investors. A huge shout out to Lydia Mapstone, PhD, Tara O'Driscoll, PhD, Megan Powell, Catherine Gurr, Rozalyn Yorke, and Ryan Ames - I can’t wait to reach this next milestone together.
BoobyBiome Secures £1.6M Innovate UK Biomedical Catalyst Grant for Groundbreaking Synbiotic Research
boobybiome.com
To view or add a comment, sign in
-
Dr. Lynne Le Sauteur and her team are in the spotlight in Insights Care’s The Top Most Innovative Bioanalytical Service Providers to Watch! Read how our experts are leading the charge in bioanalytical advancements: https://lnkd.in/dxGi48qz #Bioanalysis #DrugDevelopment #LifeSciences Lynne LeSauteur
To view or add a comment, sign in
3,302 followers